{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:23:46Z","timestamp":1724372626370},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,21]]},"DOI":"10.7759\/cureus.67397","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T01:22:33Z","timestamp":1724289753000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating Modern Therapeutic Interventions for Migraine Management: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Lovett S","family":"Achiatar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Zia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Jameel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh","family":"Raut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Shehryar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benazir","family":"Shafqat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija A","family":"Palekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyba","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moosa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.800605","article-title":"Migraine: a review on its history, global epidemiology, risk factors, and comorbidities","volume":"12","author":"Amiri P","year":"2021","unstructured":"Amiri P, Kazeminasab S, Nejadghaderi SA, et al.. Migraine: a review on its history, global epidemiology, risk factors, and comorbidities. Front Neurol. 2021, 12:800605. 10.3389\/fneur.2021.800605","journal-title":"Front Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14693","article-title":"Nonspecific oral medications versus anti-calcitonin gene-related peptide monoclonal antibodies for migraine: a\u00a0systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Robblee J","year":"2024","unstructured":"Robblee J, Hakim SM, Reynolds JM, Monteith TS, Zhang N, Barad M. Nonspecific oral medications versus anti-calcitonin gene-related peptide monoclonal antibodies for migraine: a\u00a0systematic review and meta-analysis of randomized controlled trials. Headache. 2024, 64:547-72. 10.1111\/head.14693","journal-title":"Headache"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/2042069","article-title":"Myofascial release for the treatment of tension-type, cervicogenic headache or migraine: a systematic review and meta-analysis","volume":"2024","author":"Lu Z","year":"2024","unstructured":"Lu Z, Zou H, Zhao P, Wang J, Wang R. Myofascial release for the treatment of tension-type, cervicogenic headache or migraine: a systematic review and meta-analysis. Pain Res Manag. 2024, 2024:2042069. 10.1155\/2024\/2042069","journal-title":"Pain Res Manag"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1142\/S2339547818300020","article-title":"The growing role of precision and personalized medicine for cancer treatment","volume":"6","author":"Krzyszczyk P","year":"2018","unstructured":"Krzyszczyk P, Acevedo A, Davidoff EJ, et al.. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). 2018, 6:79-100. 10.1142\/S2339547818300020","journal-title":"Technology (Singap World Sci)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01723-4","article-title":"Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials","volume":"25","author":"Deng X","year":"2024","unstructured":"Deng X, Zhou L, Liang C, et al.. Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials. J Headache Pain. 2024, 25:16. 10.1186\/s10194-024-01723-4","journal-title":"J Headache Pain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176702","article-title":"Real-world effectiveness and safety of erenumab for the treatment of migraine: a systematic review and meta-analysis","volume":"976","author":"Fern\u00e1ndez-Bravo-Rodrigo J","year":"2024","unstructured":"Fern\u00e1ndez-Bravo-Rodrigo J, Cavero-Redondo I, Lucer\u00f3n-Lucas-Torres M, Mart\u00ednez-Garc\u00eda I, Flor-Garc\u00eda A, Barreda-Hern\u00e1ndez D, Pascual-Morena C. Real-world effectiveness and safety of erenumab for the treatment of migraine: a systematic review and meta-analysis. Eur J Pharmacol. 2024, 976:176702. 10.1016\/j.ejphar.2024.176702","journal-title":"Eur J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000588","article-title":"Zavegepant for acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials","volume":"47","author":"Suresh V","year":"2024","unstructured":"Suresh V, Bardhan M, Dave T, et al.. Zavegepant for acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials. Clin Neuropharmacol. 2024, 47:72-81. 10.1097\/WNF.0000000000000588","journal-title":"Clin Neuropharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/head.14704","article-title":"The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: a\u00a0systematic review and network analysis","volume":"64","author":"Kirkland SW","year":"2024","unstructured":"Kirkland SW, Visser L, Meyer J, et al.. The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: a\u00a0systematic review and network analysis. Headache. 2024, 64:424-47. 10.1111\/head.14704","journal-title":"Headache"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-022-00452-3","article-title":"Effectiveness and safety of chronic migraine preventive treatments: a systematic literature review","volume":"12","author":"Blumenfeld AM","year":"2023","unstructured":"Blumenfeld AM, Kaur G, Mahajan A, Shukla H, Sommer K, Tung A, Knievel KL. Effectiveness and safety of chronic migraine preventive treatments: a systematic literature review. Pain Ther. 2023, 12:251-74. 10.1007\/s40122-022-00452-3","journal-title":"Pain Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-16-S1-A47","article-title":"The multimodal treatment in headaches","volume":"16","author":"Lacerenza MR","year":"2015","unstructured":"Lacerenza MR, Schoss F, Grazzi L. The multimodal treatment in headaches. J Headache Pain. 2015, 16:A47. 10.1186\/1129-2377-16-S1-A47","journal-title":"J Headache Pain"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41991","article-title":"Safety and efficacy of zavegepant in treating migraine: a systematic review","volume":"15","author":"Khan ZZ","year":"2023","unstructured":"Khan ZZ, Ahmed U, Shahzad F, et al.. Safety and efficacy of zavegepant in treating migraine: a systematic review. Cureus. 2023, 15:e41991. 10.7759\/cureus.41991","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.873179","article-title":"New approaches to shifting the migraine treatment paradigm","volume":"3","author":"Johnson B","year":"2022","unstructured":"Johnson B, Freitag FG. New approaches to shifting the migraine treatment paradigm. Front Pain Res (Lausanne). 2022, 3:873179. 10.3389\/fpain.2022.873179","journal-title":"Front Pain Res (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint15030067","article-title":"Migraine: advances in the pathogenesis and treatment","volume":"15","author":"Ple\u0219 H","year":"2023","unstructured":"Ple\u0219 H, Florian IA, Timis TL, et al.. Migraine: advances in the pathogenesis and treatment. Neurol Int. 2023, 15:1052-105. 10.3390\/neurolint15030067","journal-title":"Neurol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421989601","article-title":"Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis","volume":"41","author":"Drellia K","year":"2021","unstructured":"Drellia K, Kokoti L, Deligianni CI, Papadopoulos D, Mitsikostas DD. Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. Cephalalgia. 2021, 41:851-64. 10.1177\/0333102421989601","journal-title":"Cephalalgia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01747-w","article-title":"Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis","volume":"25","author":"Pozo-Rosich P","year":"2024","unstructured":"Pozo-Rosich P, Poveda JL, Crespo C, Mart\u00ednez M, Rodr\u00edguez JM, Irimia P. Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis. J Headache Pain. 2024, 25:40. 10.1186\/s10194-024-01747-w","journal-title":"J Headache Pain"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018483","article-title":"Erenumab safety and efficacy in migraine: a systematic review and meta-analysis of randomized clinical trials","volume":"98","author":"Zhu C","year":"2019","unstructured":"Zhu C, Guan J, Xiao H, Luo W, Tong R. Erenumab safety and efficacy in migraine: a systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore). 2019, 98:e18483. 10.1097\/MD.0000000000018483","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12468","article-title":"An overview of methodological approaches in systematic reviews","volume":"15","author":"Veginadu P","year":"2022","unstructured":"Veginadu P, Calache H, Gussy M, Pandian A, Masood M. An overview of methodological approaches in systematic reviews. J Evid Based Med. 2022, 15:39-54. 10.1111\/jebm.12468","journal-title":"J Evid Based Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ph16070934","article-title":"A scoping review and meta-analysis of anti-CGRP monoclonal antibodies: predicting response","volume":"16","author":"Hong JB","year":"2023","unstructured":"Hong JB, Lange KS, Overeem LH, Triller P, Raffaelli B, Reuter U. A scoping review and meta-analysis of anti-CGRP monoclonal antibodies: predicting response. Pharmaceuticals (Basel). 2023, 16:10.3390\/ph16070934","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_95_22","article-title":"Advances in CGRP monoclonal antibodies as migraine therapy: a narrative review","volume":"11","author":"Aditya S","year":"2023","unstructured":"Aditya S, Rattan A. Advances in CGRP monoclonal antibodies as migraine therapy: a narrative review. Saudi J Med Med Sci. 2023, 11:11-8. 10.4103\/sjmms.sjmms_95_22","journal-title":"Saudi J Med Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45560","article-title":"Efficacy and safety of anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies in preventing migraines: a systematic review","volume":"15","author":"Muddam MR","year":"2023","unstructured":"Muddam MR, Obajeun OA, Abaza A, et al.. Efficacy and safety of anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies in preventing migraines: a systematic review. Cureus. 2023, 15:e45560. 10.7759\/cureus.45560","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34553","article-title":"Revisiting migraine: the evolving pathophysiology and the expanding management armamentarium","volume":"15","author":"Gawde P","year":"2023","unstructured":"Gawde P, Shah H, Patel H, Bharathi KS, Patel N, Sethi Y, Kaka N. Revisiting migraine: the evolving pathophysiology and the expanding management armamentarium. Cureus. 2023, 15:e34553. 10.7759\/cureus.34553","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13554","article-title":"Improving diversity in study participation: patient perspectives on barriers, racial differences and the role of communities","volume":"25","author":"Shea L","year":"2022","unstructured":"Shea L, Pesa J, Geonnotti G, Powell V, Kahn C, Peters W. Improving diversity in study participation: patient perspectives on barriers, racial differences and the role of communities. Health Expect. 2022, 25:1979-87. 10.1111\/hex.13554","journal-title":"Health Expect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.935183","article-title":"Use of non-pharmacological therapies in individuals with migraine eligible for treatment with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP)-signaling: a single-center cross-sectional observational study","volume":"3","author":"Rundblad L","year":"2022","unstructured":"Rundblad L, Cullum CK, Sacco S, Gil-Gouveia R, Ulud\u00fcz D, Do TP, Amin FM. Use of non-pharmacological therapies in individuals with migraine eligible for treatment with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP)-signaling: a single-center cross-sectional observational study. Front Pain Res (Lausanne). 2022, 3:935183. 10.3389\/fpain.2022.935183","journal-title":"Front Pain Res (Lausanne)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47731","article-title":"Improving patient outcomes through effective hospital administration: a comprehensive review","volume":"15","author":"Bhati D","year":"2023","unstructured":"Bhati D, Deogade MS, Kanyal D. Improving patient outcomes through effective hospital administration: a comprehensive review. Cureus. 2023, 15:e47731. 10.7759\/cureus.47731","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012261","article-title":"Factors associated with, and mitigation strategies for, health care disparities faced by patients with headache disorders","volume":"97","author":"Kiarashi J","year":"2021","unstructured":"Kiarashi J, VanderPluym J, Szperka CL, et al.. Factors associated with, and mitigation strategies for, health care disparities faced by patients with headache disorders. Neurology. 2021, 97:280-9. 10.1212\/WNL.0000000000012261","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/277241-evaluating-modern-therapeutic-interventions-for-migraine-management-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T01:22:38Z","timestamp":1724289758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/277241-evaluating-modern-therapeutic-interventions-for-migraine-management-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.67397","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}